Transfemoral vs Transradial Approach in the Percutaneous Treatment of CTO

Percutaneous treatment of chronic total occlusion (CTO) has traditionally been via the transfemoral approach (TFA). The use of the transradial approach (TRA) in complex coronary interventions has been increasing. A randomized study assessed the use of TRA vs TFA in complex PCI (58% CTO) and TRA saw favorable outcomes.

Acceso femoral vs Acceso radial en el tratamiento percutáneo de CTO

The aim of this prospective, randomized, non-inferiority study was to compare TRA vs TFA in the percutaneous treatment of chronic total occlusions. 

Primary end point was procedural success defined as the absence of death, AMI, target vessel PCI or CABG, cardiac tamponade, and stroke. 

Secondary end point was incidence of major complications to the access site, including major bleeding, vascular complications requiring intervention or ≥ 10 cm diameter hematoma. 

610 patients were randomized: 305 to TRA, and 305 to TFA. Mean age was 61. Most patients were men. The most treated vessel was the right coronary artery, followed by the anterior descending. 

Crossover rate was similar in both groups. J-CTO score was 2.1 (TRA) vs 2.2 (TFA), PROGRESS CTO score was 1.3 vs 1.1, and PROGRESS CTO complication score was 2.4 vs 2.3.  

Read also: Should Total Occlusion Influence on Revascularization Strategy?

CTO intervention was indicated when there was 85% symptom presence, followed by 5% ischemia presence. Dual access was less frequently used in the TRA group.  

As regards results, TRA was non-inferior to the transfemoral approach when it came to procedural success. However, the transradial approach presented lower access site complications rate (2.0% vs 5.6%; P = 0.019). Finally, there were no differences in procedure duration, contrast volume or radiation dose between the groups. 

Conclusion

Compared to the transfemoral approach, the TRA was non-inferior in terms of procedural success but had fewer access site complications. 

Dr. Andrés Rodríguez
Member of the Editorial Board of SOLACI.org.

Original Title: Femoral or Radial Approach in Treatment of Coronary Chronic Total Occlusion A Randomized Clinical Trial.

Reference: Sevket Gorgulu, MD et al J Am Coll Cardiol Intv 2022;15:823–830.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

CRABBIS Trial: Comparison of Different Provisional Stenting Sequences

Provisional stenting (PS) is the gold standard for percutaneous coronary intervention (PCI) in most patients with coronary bifurcation lesions (CBL). Moreover, recent studies such...

Andromeda Trial: Meta-Analysis of Drug Coated Balloon vs. DES in Small Vessel DeNovo Lesions

The use of coronary stents vs plain old balloon angioplasty (POBA), has allowed to reduce recoil and limiting flow dissection which were major limitation...

QFR vs. FFR: Is Coronary Revascularization Deferral Safe? Results from a FAVOR III Sub-Analysis

In cases of intermediate coronary lesions, functional assessment is recommended to aid the decision-making process regarding revascularization. There are several tools currently used to...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...

STRIDE: Semaglutide in Patients with Peripheral Arterial Disease and Type II Diabetes

Peripheral arterial disease (PAD) is a severe complication in patients with type II diabetes, primarily affecting peripheral vessels, especially below-the-knee (BTK) arteries. This condition...